332 related articles for article (PubMed ID: 26179998)
1. Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects.
Patil KR; Goyal SN; Sharma C; Patil CR; Ojha S
Curr Med Chem; 2015; 22(30):3472-501. PubMed ID: 26179998
[TBL] [Abstract][Full Text] [Related]
2. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents.
Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M
CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187
[TBL] [Abstract][Full Text] [Related]
3. Endocannabinoid system and mood disorders: priming a target for new therapies.
Micale V; Di Marzo V; Sulcova A; Wotjak CT; Drago F
Pharmacol Ther; 2013 Apr; 138(1):18-37. PubMed ID: 23261685
[TBL] [Abstract][Full Text] [Related]
4. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.
Aly E; Masocha W
IBRO Neurosci Rep; 2021 Jun; 10():109-118. PubMed ID: 34179865
[TBL] [Abstract][Full Text] [Related]
5. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic potential of cannabinoids in schizophrenia.
Kucerova J; Tabiova K; Drago F; Micale V
Recent Pat CNS Drug Discov; 2014 Apr; 9(1):13-25. PubMed ID: 24605939
[TBL] [Abstract][Full Text] [Related]
7. FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels.
Petrosino S; Di Marzo V
Curr Opin Investig Drugs; 2010 Jan; 11(1):51-62. PubMed ID: 20047159
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation.
Galve-Roperh I; Chiurchiù V; Díaz-Alonso J; Bari M; Guzmán M; Maccarrone M
Prog Lipid Res; 2013 Oct; 52(4):633-50. PubMed ID: 24076098
[TBL] [Abstract][Full Text] [Related]
9. Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors.
van Egmond N; Straub VM; van der Stelt M
Annu Rev Pharmacol Toxicol; 2021 Jan; 61():441-463. PubMed ID: 32867595
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB
Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH
Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548
[TBL] [Abstract][Full Text] [Related]
11. Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids.
Wiley JL; Owens RA; Lichtman AH
Curr Top Behav Neurosci; 2018; 39():153-173. PubMed ID: 27278640
[TBL] [Abstract][Full Text] [Related]
12. Medicinal chemistry of cannabinoids.
Vemuri VK; Makriyannis A
Clin Pharmacol Ther; 2015 Jun; 97(6):553-8. PubMed ID: 25801236
[TBL] [Abstract][Full Text] [Related]
13. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid system.
Gertsch J
Planta Med; 2008 May; 74(6):638-50. PubMed ID: 18275004
[TBL] [Abstract][Full Text] [Related]
14. Small Molecules from Nature Targeting G-Protein Coupled Cannabinoid Receptors: Potential Leads for Drug Discovery and Development.
Sharma C; Sadek B; Goyal SN; Sinha S; Kamal MA; Ojha S
Evid Based Complement Alternat Med; 2015; 2015():238482. PubMed ID: 26664449
[TBL] [Abstract][Full Text] [Related]
15. Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon?
Androvicova R; Horacek J; Stark T; Drago F; Micale V
Pharmacol Res; 2017 Jan; 115():200-208. PubMed ID: 27884725
[TBL] [Abstract][Full Text] [Related]
16. Targeting the endocannabinoid system as a potential anticancer approach.
Schwarz R; Ramer R; Hinz B
Drug Metab Rev; 2018 Feb; 50(1):26-53. PubMed ID: 29390896
[TBL] [Abstract][Full Text] [Related]
17. Druggable Targets in Endocannabinoid Signaling.
Gregus AM; Buczynski MW
Adv Exp Med Biol; 2020; 1274():177-201. PubMed ID: 32894511
[TBL] [Abstract][Full Text] [Related]
18. Targeting Cannabinoid Signaling in the Immune System: "High"-ly Exciting Questions, Possibilities, and Challenges.
Oláh A; Szekanecz Z; Bíró T
Front Immunol; 2017; 8():1487. PubMed ID: 29176975
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid system: An overview of its potential in current medical practice.
Mouslech Z; Valla V
Neuro Endocrinol Lett; 2009; 30(2):153-79. PubMed ID: 19675519
[TBL] [Abstract][Full Text] [Related]
20. The Endocannabinoid System of Animals.
Silver RJ
Animals (Basel); 2019 Sep; 9(9):. PubMed ID: 31527410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
